<< Read Full Article
<< Read Full Article
MiddleBrook Sinks as Buyout Hopes Fade
MiddleBrook Pharmaceuticals (MBRK Quote) couldn't find a buyer.
The Germantown, Md.-based drugmaker said Wednesday that an outside investment group will pump $100 million into the company to fund the commercial launch of its recently approved antibiotic Moxatag on its own.
The announcement means that an outright sale of MiddleBrook is off the table -- disappointing news that sent MiddleBrook shares tumbling in premarket trading Wednesday.
The stock was losing $1.58, or 51.5%, to $1.49 in recent trading before the opening bell. ...
Recent Comments
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,413.54 | 1,114.90 | 2,235.52 | 36.15 |
Oil *
74.36
|
|
UP
84.65
|
UP
12.43
|
UP
23.83
|
UP
0.69
|
10 Yr
3.62%
SPDR Gold
108.72
|
|
+0.82%
|
+1.13%
|
+1.08%
|
+1.95%
|
Data delayed 20 minutes |
Connect with TheStreet